Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Ahran D Arnold Added: 7 months ago
ESC Congress 2025 - EMORI-HCM finds that right ventricular pacing (iRVP) improves symptoms in obstructive hypertrophic cardiomyopathy (oHCM) patients.Dr Ahran Arnold (Imperial College London, UK) discusses findings from the EMORI-HCM study, exploring electro-mechanically optimised right ventricular pacing as a novel therapeutic approach for patients with oHCM.This interventional trial examined… View more
Author(s): Pugazhendhi Vijayaraman , Kenneth Ellenbogen Added: 5 days ago
EHRA Congress 2026 — Dr Pugazhendi Vijayaraman (Geisinger Heart Institute, Wilkes-Barre, PA, US) and Dr Kenneth Ellenbogen (Virginia Commonwealth University School of Medicine, Richmond, VA, US) come together for an expert discussion on one of the most debated questions in cardiac pacing — whether conduction system pacing (CSP) is ready to replace cardiac resynchronisation therapy, or whether the… View more
Author(s): Kent Nilsson Added: 5 days ago
EHRA 2026 — Dr Kent Nilsson (Piedmont Athens Regional Hospital, Athens, GA, USA) joins us to discuss 1-year outcomes from the ARRIVE study, evaluating the Abbott Aveir AR atrial leadless pacemaker against single-chamber atrial transvenous pacemakers in a real-world Medicare population.This prospective, observational coverage with evidence development (CED) study leverages real-world data from… View more
Added: 2 months ago Source:  Radcliffe Cardiology
For patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), the net effect of right ventricular pacing (RVP) has been variable, as it can reduce the left ventricular outflow tract gradient (LVOTg) but may also decrease cardiac output.¹ The EMORI-HCM trial investigated whether electromechanically optimising the atrio-ventricular delay (AVD) could allow RVP to achieve a consistent… View more